Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antitumor gene therapy using suicide genes]

M Berenstein1, S Adris, F Ledda

  • 1Fundación Campomar, Facultad de Medicina Universidad de Buenos Aires, Argentina.

Medicina
|August 26, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multidisciplinary management of X-linked myotubular myopathy in Spain and Portugal: A case series analysis.

Neurologia·2026
Same author

Barium ion sensing with IPG K<sup>+</sup> molecular probes.

The Analyst·2025
Same author

ICDAS Adaptation for Early Childhood Caries: An Epidemiological Study in 11 Latin American Countries.

JDR clinical and translational research·2025
Same author

Open fracture of the distal radius with complete laceration of the median nerve.

Acta ortopedica mexicana·2025
Same author

Adolescents with intellectual disability in residential child care: Double vulnerability.

Journal of intellectual & developmental disability·2025
Same author

Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real-world retrospective study from Spain and systematic review of the published data.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same journal

Detection of VIM-3 in oral squamous cell carcinomas: methodological limitations.

Medicina·2026
Same journal

The importance of specific antibodies in VIM-3 research: addressing a key methodological flaw.

Medicina·2026
Same journal

[From the right to be cared for to the duty to care: Legal bases for the implementation of palliative care in Argentina].

Medicina·2026
Same journal

[Surrogacy].

Medicina·2026
Same journal

[The misunderstandings in interpreting the "diagnostic superiority of Artificial Intelligence" and the explainable Artificial Intelligence].

Medicina·2026
Same journal

[Artificial intelligence in medicine: between algorithmic opacity and clinical responsibility].

Medicina·2026
See all related articles

This study shows that suicide gene therapy using herpes simplex-1 virus thymidine kinase (HSV-tk) and ganciclovir (GVC) effectively inhibits tumor growth and enhances survival in brain tumor models, potentially involving immune system activation.

Area of Science:

  • Oncology
  • Gene Therapy
  • Immunology

Context:

  • Cancer gene therapy utilizes suicide genes to eliminate tumor cells.
  • The herpes simplex-1 virus thymidine kinase (HSV-tk)/ganciclovir (GVC) system converts GVC into a toxic metabolite for dividing cells.
  • A bystander effect enhances therapeutic efficacy by eliminating non-modified surrounding tumor cells.

Purpose:

  • To evaluate the efficacy of HSV-tk/GVC suicide gene therapy in preclinical models of human melanoma, murine melanoma, and rat glioblastoma.
  • To assess tumor growth inhibition and long-term survival following gene therapy.
  • To investigate the immune response and potential for tumor eradication.

Summary:

  • HSV-tk gene therapy combined with GVC administration demonstrated significant tumor growth inhibition across three models.

Related Experiment Videos

  • Long-term studies with a rat glioma model showed a 50% survival rate beyond 75 days and rejection of subsequent tumor challenges.
  • Histological analysis revealed inflammatory infiltrates, suggesting immune system involvement in tumor eradication.

    • Impact:

    • Suicide gene therapy, particularly the HSV-tk/GVC system, shows promise as an effective treatment for brain tumors.
    • The observed bystander effect and immune response highlight the potential for complete tumor eradication.
    • This approach may offer a novel therapeutic strategy for managing brain tumors and their spread.